Autopsy report · NCT03374709
Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia
Cause of deathDrug or device supply, also staffing, sites or logistics
“Resource and time constraints were encountered by product manufacturer and study team.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Conditions
- Trigeminal Neuralgia
- Interventions
- Oxtellar XR 150Mg Extended Release Tablet
- Participants
- 0
Trials that died the same way
- A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma
“Company's resource optimization and product's development change”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.